Eli Lilly and Company (LLY)
NYSE: LLY · Real-Time Price · USD
1,409.38
-1.61 (-0.11%)
At close: Nov 3, 2026, 4:00 PM EST
1,419.11
+9.73 (0.69%)
Pre-market: Nov 4, 2026, 4:00 AM EST
Eli Lilly Stock Forecast
Stock Price Forecast
According to 31 analysts polled by S&P Global, Eli Lilly stock has a consensus rating of "Buy" and an average price target of $1,442. The average 1-year stock price forecast is 2.32% higher than the current stock price, while the lowest is $930 (-34.01%) and the highest is $1,690 (+19.91%).
Price Target: $1,442 (+2.32%)
Analyst Consensus: Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for Eli Lilly stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Jun '26 | Jul '26 | Aug '26 | Sep '26 | Oct '26 | Nov '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 17 | 17 | 18 | 19 | 20 | 20 |
| Buy | 6 | 5 | 6 | 6 | 6 | 6 |
| Hold | 5 | 4 | 4 | 3 | 3 | 3 |
| Sell | 1 | 1 | 1 | 1 | 1 | 1 |
| Strong Sell | 1 | 1 | 1 | 1 | 1 | 1 |
| Total | 30 | 28 | 30 | 30 | 31 | 31 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Leerink Partners | Leerink Partners | Buy Maintains $1,316 → $1,508 | Buy | Maintains | $1,316 → $1,508 | +7.00% | Nov 2, 2026 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Maintains $1,440 → $1,600 | Buy | Maintains | $1,440 → $1,600 | +13.53% | Nov 2, 2026 |
| BMO Capital | BMO Capital | Buy Maintains $1,400 → $1,650 | Buy | Maintains | $1,400 → $1,650 | +17.07% | Nov 2, 2026 |
| Freedom Capital Markets | Freedom Capital Markets | Buy Maintains $1,400 → $1,600 | Buy | Maintains | $1,400 → $1,600 | +13.53% | Oct 30, 2026 |
| Morgan Stanley | Morgan Stanley | Buy Maintains $1,430 → $1,596 | Buy | Maintains | $1,430 → $1,596 | +13.24% | Oct 30, 2026 |
Financial Forecast
Revenue This Year
91.86B
from 65.18B
Increased by 40.93%
Revenue Next Year
105.96B
from 91.86B
Increased by 15.35%
EPS This Year
35.35
from 24.21
Increased by 46.02%
EPS Next Year
50.15
from 35.35
Increased by 41.87%
EPS and Forward PE are based on non-GAAP adjusted numbers.